Estimation of CYP2 D6*10 genotypes on citalopram disposition in Chinese subjects by population pharmacokinetic assay.

What is known and objective There is great interindividual variability in citalopram ( CIT) pharmacokinetics. We attempted to establish a population pharmacokinetic ( PPK) model of CIT in Chinese healthy subjects, to evaluate the effect of genetic polymorphism on CIT pharmacokinetics and to compare...

Descripción completa

Detalles Bibliográficos

Publicado en:	Journal of Clinical Pharmacy & Therapeutics Vol. 38; no. 6; pp. 504 - 512
Autores principales:	Chen, B., Xu, Y., Jiang, T., Feng, R., Sun, J., Zhang, W., Yang, W., Li, J., Adeniyi, O., Chen, H.
Formato:	equations & formulas research tables/charts randomized controlled trial Journal Article
Publicado:	Wiley-Blackwell Dec2013
Acceso en línea:	Ver este registro en EBSCOhost